{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T04:19:58Z","timestamp":1683951598126},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00347-023-01854-0","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T20:29:31Z","timestamp":1682368171000},"page":"472-477","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Klinik des okul\u00e4ren Schleimhautpemphigoids","Clinical aspects of ocular mucosal pemphigoid"],"prefix":"10.1007","volume":"120","author":[{"given":"M.","family":"Roth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Yaici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Geerling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,24]]},"reference":[{"key":"1854_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3238\/arztebl.m2021.0136","volume":"118","author":"N van Beek","year":"2021","unstructured":"van Beek\u00a0N, Zillikens\u00a0D, Schmidt\u00a0E (2021) Bullous autoimmune dermatoses: clinical features, diagnostic evaluation, and treatment options. Dtsch Arztebl Int 118:413\u2013420. https:\/\/doi.org\/10.3238\/arztebl.m2021.0136","journal-title":"Dtsch Arztebl Int"},{"key":"1854_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","volume":"54","author":"KT Amber","year":"2018","unstructured":"Amber\u00a0KT, Murrell\u00a0DF, Schmidt\u00a0E et\u00a0al (2018) Autoimmune subepidermal bullous diseases of the skin and mucosae: Clinical features, diagnosis, and management. Clin Rev Allergy Immunol 54:26\u201351. https:\/\/doi.org\/10.1007\/s12016-017-8633-4","journal-title":"Clin Rev Allergy Immunol"},{"key":"1854_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17397","author":"H Rashid","year":"2021","unstructured":"Rashid\u00a0H, Lamberts\u00a0A, Borradori\u00a0L et\u00a0al (2021) European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology \u2013 Part I. J\u00a0Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.17397","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1854_CR4","unstructured":"S2k-Leitlinie Diagnostik und Therapie des Schleimhautpemphigoid. AWMF-Register-Nr: 013-102, 2022"},{"key":"1854_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1610-0387.2008.06976.x","volume":"7","author":"F Bertram","year":"2009","unstructured":"Bertram\u00a0F, Br\u00f6cker\u00a0E, Zillikens\u00a0D, Schmidt\u00a0E (2009) Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. JDDG 7:434\u2013439. https:\/\/doi.org\/10.1111\/j.1610-0387.2008.06976.x","journal-title":"JDDG"},{"key":"1854_CR6","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/jdv.17107","volume":"35","author":"N Beek","year":"2021","unstructured":"Beek\u00a0N, Weidinger\u00a0A, Schneider\u00a0SW et al (2021) Incidence of pemphigoid diseases in Northern Germany in 2016\u2014first data from the Schleswig-Holstein Registry of Autoimmune Bullous Diseases. J\u00a0Eur Acad Dermatol Venereol 35:1197\u20131202. https:\/\/doi.org\/10.1111\/jdv.17107","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1854_CR7","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","volume":"136","author":"F H\u00fcbner","year":"2016","unstructured":"H\u00fcbner\u00a0F, Recke\u00a0A, Zillikens\u00a0D et\u00a0al (2016) Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany. J\u00a0Invest Dermatol 136:2495\u20132498. https:\/\/doi.org\/10.1016\/j.jid.2016.07.013","journal-title":"J Invest Dermatol"},{"key":"1854_CR8","doi-asserted-by":"publisher","DOI":"10.1055\/a-1720-1819","author":"R Ya\u00efci","year":"2022","unstructured":"Ya\u00efci\u00a0R, Roth\u00a0M, Juergens\u00a0L et\u00a0al (2022) Zur Versorgungssituation und konservativen Therapie des okul\u00e4ren vernarbenden Schleimhautpemphigoids in Deutschland. Klin Monatsbl Augenheilkd. https:\/\/doi.org\/10.1055\/a-1720-1819","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1854_CR9","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/eye.2012.119","volume":"26","author":"CF Radford","year":"2012","unstructured":"Radford\u00a0CF, Rauz\u00a0S, Williams\u00a0GP et\u00a0al (2012) Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom. Eye 26:1199\u20131208. https:\/\/doi.org\/10.1038\/eye.2012.119","journal-title":"Eye"},{"key":"1854_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2018.1455879","volume":"27","author":"GH Hong","year":"2018","unstructured":"Hong\u00a0GH, Khan\u00a0IR, Shifera\u00a0AS et\u00a0al (2018) Incidence and clinical characteristics of ocular involvement in mucous membrane pemphigoid. Ocul Immunol Inflamm 27:1\u20135. https:\/\/doi.org\/10.1080\/09273948.2018.1455879","journal-title":"Ocul Immunol Inflamm"},{"key":"1854_CR11","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1136\/bjo.2006.092528","volume":"90","author":"GT Higgins","year":"2006","unstructured":"Higgins\u00a0GT, Allan\u00a0RB, Hall\u00a0R et\u00a0al (2006) Development of ocular disease in patients with mucous membrane pemphigoid involving the oral mucosa. Br J Ophthalmol 90:964. https:\/\/doi.org\/10.1136\/bjo.2006.092528","journal-title":"Br J Ophthalmol"},{"key":"1854_CR12","doi-asserted-by":"publisher","first-page":"730","DOI":"10.18240\/ijo.2016.05.17","volume":"9","author":"Q Long","year":"2016","unstructured":"Long\u00a0Q, Zuo\u00a0Y\u2011G, Yang\u00a0X et al (2016) Clinical features and in vivo confocal microscopy assessment in 12\u00a0patients with ocular cicatricial pemphigoid. Int J Ophthalmol 9:730\u2013737. https:\/\/doi.org\/10.18240\/ijo.2016.05.17","journal-title":"Int J Ophthalmol"},{"key":"1854_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ophtha.2017.10.004","volume":"125","author":"HS Ong","year":"2017","unstructured":"Ong\u00a0HS, Setterfield\u00a0JF, Minassian\u00a0DC et\u00a0al (2017) Mucous membrane pemphigoid with ocular involvement the clinical phenotype and its relationship to direct immunofluorescence findings. Ophthalmology 125:496\u2013504. https:\/\/doi.org\/10.1016\/j.ophtha.2017.10.004","journal-title":"Ophthalmology"},{"key":"1854_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ajo.2017.08.009","volume":"183","author":"MT Labowsky","year":"2017","unstructured":"Labowsky\u00a0MT, Stinnett\u00a0SS, Liss\u00a0J et\u00a0al (2017) Clinical implications of direct immunofluorescence findings in patients with ocular mucous membrane pemphigoid. Am J Ophthalmol 183:48\u201355. https:\/\/doi.org\/10.1016\/j.ajo.2017.08.009","journal-title":"Am J Ophthalmol"},{"key":"1854_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mexoft.2016.04.013","volume":"91","author":"EH Chiganer","year":"2017","unstructured":"Chiganer\u00a0EH, Albera\u00a0P (2017) Ocular cicatricial pemphigoid: Conjunctival biopsy findings and its relationship to ocular\u2019s inflammation and scarring. Rev Mex Oftalmol 91:134\u2013141. https:\/\/doi.org\/10.1016\/j.mexoft.2016.04.013","journal-title":"Rev Mex Oftalmol"},{"key":"1854_CR16","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3969\/j.issn.1672-5123.2010.09.072","volume":"10","author":"X Hui","year":"2010","unstructured":"Hui\u00a0X, Zhang\u00a0H (2010) Analysis of clinical characteristics of cicatricial pemphigoid in 35\u00a0cases. Int J Ophthalmol 10:1829\u20131831. https:\/\/doi.org\/10.3969\/j.issn.1672-5123.2010.09.072","journal-title":"Int J Ophthalmol"},{"key":"1854_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/bf00160769","volume":"82","author":"CS Foster","year":"1992","unstructured":"Foster\u00a0CS, Neumann\u00a0R, Tauber\u00a0J (1992) Long term results of systemic chemotherapy for ocular cicatricial pemphigoid. Doc Ophthalmol 82:223\u2013229. https:\/\/doi.org\/10.1007\/bf00160769","journal-title":"Doc Ophthalmol"},{"key":"1854_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ophtha.2003.03.001","volume":"111","author":"JE Thorne","year":"2004","unstructured":"Thorne\u00a0JE, Anhalt\u00a0GJ, Jabs\u00a0DA (2004) Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology 111:45\u201352. https:\/\/doi.org\/10.1016\/j.ophtha.2003.03.001","journal-title":"Ophthalmology"},{"key":"1854_CR19","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1111\/jdv.16467","volume":"34","author":"F H\u00fcbner","year":"2020","unstructured":"H\u00fcbner\u00a0F, K\u00f6nig\u00a0IR, Holtsche\u00a0MM et\u00a0al (2020) Prevalence and age distribution of pemphigus and pemphigoid diseases among paediatric patients in Germany. J\u00a0Eur Acad Dermatol Venereol 34:2600\u20132605. https:\/\/doi.org\/10.1111\/jdv.16467","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1854_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1525-1470.2009.01079.x","volume":"27","author":"M Kharfi","year":"2010","unstructured":"Kharfi\u00a0M, Khaled\u00a0A, Anane\u00a0R et\u00a0al (2010) Early onset childhood cicatricial pemphigoid: a case report and review of the literature. Pediatr Dermatol 27:119\u2013124. https:\/\/doi.org\/10.1111\/j.1525-1470.2009.01079.x","journal-title":"Pediatr Dermatol"},{"key":"1854_CR21","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/pde.13971","volume":"36","author":"V Flores-Climente","year":"2019","unstructured":"Flores-Climente\u00a0V, Rozas-Mu\u00f1oz\u00a0E, Mart\u00ednez-Grau\u00a0A et al (2019) Childhood ocular mucous membrane pemphigoid successfully treated with rituximab. Pediatr Dermatol 36:984\u2013985. https:\/\/doi.org\/10.1111\/pde.13971","journal-title":"Pediatr Dermatol"},{"key":"1854_CR22","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.ophtha.2005.01.039","volume":"112","author":"S Rauz","year":"2005","unstructured":"Rauz\u00a0S, Maddison\u00a0PG, Dart\u00a0JKG (2005) Evaluation of mucous membrane pemphigoid with ocular involvement in young patients. Ophthalmology 112:1268\u20131274. https:\/\/doi.org\/10.1016\/j.ophtha.2005.01.039","journal-title":"Ophthalmology"},{"key":"1854_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/s0738-081x(00)00196-6","volume":"19","author":"LS Chan","year":"2001","unstructured":"Chan\u00a0LS (2001) Mucous membrane pemphigoid. Clin Dermatol 19:703\u2013711. https:\/\/doi.org\/10.1016\/s0738-081x(00)00196-6","journal-title":"Clin Dermatol"},{"key":"1854_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1067\/mjd.2000.107248","volume":"43","author":"TE Fleming","year":"2000","unstructured":"Fleming\u00a0TE, Korman\u00a0NJ (2000) Cicatricial pemphigoid. J\u00a0Am Acad Dermatol 43:571\u2013594. https:\/\/doi.org\/10.1067\/mjd.2000.107248","journal-title":"J Am Acad Dermatol"},{"key":"1854_CR25","first-page":"527","volume":"84","author":"CS Foster","year":"1986","unstructured":"Foster\u00a0CS (1986) Cicatricial pemphigoid. Trans Am Ophthalmol Soc 84:527\u2013663","journal-title":"Trans Am Ophthalmol Soc"},{"key":"1854_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1055\/s-0033-1358217","volume":"233","author":"T Meyer-ter-Vehn","year":"2016","unstructured":"Meyer-ter-Vehn\u00a0T (2016) Nicht infekti\u00f6se Bindehauterkrankungen. Klin Monatsbl Augenheilkd 233:547\u2013564. https:\/\/doi.org\/10.1055\/s-0033-1358217","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1854_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s0161-6420(01)00863-6","volume":"109","author":"E Miserocchi","year":"2002","unstructured":"Miserocchi\u00a0E, Baltatzis\u00a0S, Roque\u00a0MR et\u00a0al (2002) The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Ophthalmology 109:111\u2013118. https:\/\/doi.org\/10.1016\/s0161-6420(01)00863-6","journal-title":"Ophthalmology"},{"key":"1854_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ophtha.2007.04.027","volume":"115","author":"VPJ Saw","year":"2007","unstructured":"Saw\u00a0VPJ, Dart\u00a0JKG, Rauz\u00a0S et\u00a0al (2007) Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes. Ophthalmology 115:253\u2013261.e1. https:\/\/doi.org\/10.1016\/j.ophtha.2007.04.027","journal-title":"Ophthalmology"},{"key":"1854_CR29","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/eye.2011.175","volume":"25","author":"GP Williams","year":"2011","unstructured":"Williams\u00a0GP, Radford\u00a0C, Nightingale\u00a0P et\u00a0al (2011) Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom. Eye 25:1207\u20131218. https:\/\/doi.org\/10.1038\/eye.2011.175","journal-title":"Eye"},{"key":"1854_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ajpath.2010.11.013","volume":"178","author":"VPJ Saw","year":"2011","unstructured":"Saw\u00a0VPJ, Schmidt\u00a0E, Offiah\u00a0I et\u00a0al (2011) Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid. Am J Pathol 178:187\u2013197. https:\/\/doi.org\/10.1016\/j.ajpath.2010.11.013","journal-title":"Am J Pathol"},{"key":"1854_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0161-6420(81)35069-6","volume":"88","author":"BJ Mondino","year":"1981","unstructured":"Mondino\u00a0BJ, Brown\u00a0SI (1981) Ocular cicatricial pemphigoid. Ophthalmology 88:95\u2013100. https:\/\/doi.org\/10.1016\/s0161-6420(81)35069-6","journal-title":"Ophthalmology"},{"key":"1854_CR32","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-0031-1299403","volume":"229","author":"E Mameletzi","year":"2012","unstructured":"Mameletzi\u00a0E, Hamedani\u00a0M, Majo\u00a0F, Guex-Crosier\u00a0Y (2012) Clinical manifestations of mucous membrane pemphigoid in a\u00a0tertiary center. Klin Monatsbl Augenheilkd 229:416\u2013419. https:\/\/doi.org\/10.1055\/s-0031-1299403","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1854_CR33","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/ddg.12716","volume":"13","author":"T Mehra","year":"2015","unstructured":"Mehra\u00a0T, Guenova\u00a0E, Dechent\u00a0F et\u00a0al (2015) Diagnostic relevance of direct immunofluorescence in ocular mucous membrane pemphigoid. JDDG 13:1268\u20131274. https:\/\/doi.org\/10.1111\/ddg.12716","journal-title":"JDDG"},{"key":"1854_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jcjo.2014.11.012","volume":"50","author":"Y Goldich","year":"2015","unstructured":"Goldich\u00a0Y, Ziai\u00a0S, Artornsombudh\u00a0P et\u00a0al (2015) Characteristics of patients with ocular cicatricial pemphigoid referred to major tertiary hospital. Can J Ophthalmol 50:137\u2013142. https:\/\/doi.org\/10.1016\/j.jcjo.2014.11.012","journal-title":"Can J Ophthalmol"},{"key":"1854_CR35","first-page":"141","volume":"99","author":"P Wright","year":"1979","unstructured":"Wright\u00a0P (1979) Enigma of ocular cicatricial pemphigoid. A comparative study of clinical and immunological findings. Trans Ophthalmol Soc U\u00a0K 99:141\u2013145","journal-title":"Trans Ophthalmol Soc U K"},{"key":"1854_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/eye.2016.284","volume":"31","author":"JK Dart","year":"2017","unstructured":"Dart\u00a0JK (2017) The 2016 bowman lecture conjunctival curses: Scarring conjunctivitis 30\u00a0years on. Eye 31:301\u2013332. https:\/\/doi.org\/10.1038\/eye.2016.284","journal-title":"Eye"},{"key":"1854_CR37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/bjo.80.4.292","volume":"80","author":"MJ Elder","year":"1996","unstructured":"Elder\u00a0MJ, Bernauer\u00a0W, Leonard\u00a0J et\u00a0al (1996) Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol 80:292\u2013296","journal-title":"Br J Ophthalmol"},{"key":"1854_CR38","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41433-018-0155-7","volume":"32","author":"S Bobba","year":"2018","unstructured":"Bobba\u00a0S, Devlin\u00a0C, Girolamo\u00a0ND et\u00a0al (2018) Incidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand. Eye 32:1636\u20131643. https:\/\/doi.org\/10.1038\/s41433-018-0155-7","journal-title":"Eye"},{"key":"1854_CR39","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ophtha.2013.09.033","volume":"121","author":"IJ Khan","year":"2014","unstructured":"Khan\u00a0IJ, Ghauri\u00a0A\u2011J, Hodson\u00a0J et al (2014) Defining the limits of normal conjunctival Fornix anatomy in a\u00a0healthy South Asian population. Ophthalmology 121:492\u2013497. https:\/\/doi.org\/10.1016\/j.ophtha.2013.09.033","journal-title":"Ophthalmology"},{"key":"1854_CR40","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/eye.2016.128","volume":"30","author":"G Jutley","year":"2016","unstructured":"Jutley\u00a0G, Carpenter\u00a0D, Hau\u00a0S et\u00a0al (2016) Upper and lower conjunctival fornix depth in healthy white caucasian eyes: a\u00a0method of objective assessment. Eye 30:1351\u20131358. https:\/\/doi.org\/10.1038\/eye.2016.128","journal-title":"Eye"},{"key":"1854_CR41","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/bjo.2010.188011","volume":"95","author":"GP Williams","year":"2011","unstructured":"Williams\u00a0GP, Saw\u00a0VPJ, Saeed\u00a0T et\u00a0al (2011) Validation of a\u00a0fornix depth measurer: a\u00a0putative tool for the assessment of progressive cicatrising conjunctivitis. Br J Ophthalmol 95:842. https:\/\/doi.org\/10.1136\/bjo.2010.188011","journal-title":"Br J Ophthalmol"},{"key":"1854_CR42","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/eye.2008.205","volume":"23","author":"T Kawakita","year":"2009","unstructured":"Kawakita\u00a0T, Kawashima\u00a0M, Murat\u00a0D et\u00a0al (2009) Measurement of fornix depth and area: a\u00a0novel method of determining the severity of fornix shortening. Eye 23:1115\u20131119. https:\/\/doi.org\/10.1038\/eye.2008.205","journal-title":"Eye"},{"key":"1854_CR43","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1097\/ico.0000000000002770","volume":"40","author":"AY Cheung","year":"2021","unstructured":"Cheung\u00a0AY, Sarnicola\u00a0E, Denny\u00a0MR et\u00a0al (2021) Limbal stem cell deficiency: Demographics and clinical characteristics of a\u00a0large retrospective series at a\u00a0single tertiary referral center. Cornea 40:1525\u20131531. https:\/\/doi.org\/10.1097\/ico.0000000000002770","journal-title":"Cornea"},{"key":"1854_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jtos.2019.10.010","volume":"18","author":"HS Ong","year":"2020","unstructured":"Ong\u00a0HS, Minassian\u00a0D, Rauz\u00a0S et\u00a0al (2020) Validation of a\u00a0clinical assessment tool for cicatrising conjunctivitis. Ocul Surf 18:121\u2013129. https:\/\/doi.org\/10.1016\/j.jtos.2019.10.010","journal-title":"Ocul Surf"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01854-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-023-01854-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01854-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T16:14:34Z","timestamp":1683908074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-023-01854-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1854"],"URL":"https:\/\/doi.org\/10.1007\/s00347-023-01854-0","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,24]]},"assertion":[{"value":"24 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In dem Originalbeitrag wurde die Affiliation von Herrn Dr. Roth versehentlich doppelt angegeben.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Roth, R.\u00a0Yaici und G.\u00a0Geerling geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}